FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37549946> ?p ?o ?g. }

• Q37549946 description "article científic" @default.
• Q37549946 description "article scientifique" @default.
• Q37549946 description "articolo scientifico" @default.
• Q37549946 description "artigo científico" @default.
• Q37549946 description "artículu científicu espublizáu en 2009" @default.
• Q37549946 description "bilimsel makale" @default.
• Q37549946 description "scientific article published on 14 July 2009" @default.
• Q37549946 description "vedecký článok" @default.
• Q37549946 description "vetenskaplig artikel" @default.
• Q37549946 description "videnskabelig artikel" @default.
• Q37549946 description "vědecký článek" @default.
• Q37549946 description "wetenschappelijk artikel" @default.
• Q37549946 description "wissenschaftlicher Artikel" @default.
• Q37549946 description "наукова стаття, опублікована в липні 2009" @default.
• Q37549946 description "научни чланак" @default.
• Q37549946 description "مقالة علمية نشرت في 14 يوليو 2009" @default.
• Q37549946 name "Measuring therapeutic efficacy in the changing paradigm of castrate-resistant prostate cancer" @default.
• Q37549946 name "Measuring therapeutic efficacy in the changing paradigm of castrate-resistant prostate cancer" @default.
• Q37549946 name "Measuring therapeutic efficacy in the changing paradigm of castrate-resistant prostate cancer" @default.
• Q37549946 type Item @default.
• Q37549946 label "Measuring therapeutic efficacy in the changing paradigm of castrate-resistant prostate cancer" @default.
• Q37549946 label "Measuring therapeutic efficacy in the changing paradigm of castrate-resistant prostate cancer" @default.
• Q37549946 label "Measuring therapeutic efficacy in the changing paradigm of castrate-resistant prostate cancer" @default.
• Q37549946 prefLabel "Measuring therapeutic efficacy in the changing paradigm of castrate-resistant prostate cancer" @default.
• Q37549946 prefLabel "Measuring therapeutic efficacy in the changing paradigm of castrate-resistant prostate cancer" @default.
• Q37549946 prefLabel "Measuring therapeutic efficacy in the changing paradigm of castrate-resistant prostate cancer" @default.
• Q37549946 P1433 Q37549946-07E4F13F-0B9B-429A-A016-2A2D10E13305 @default.
• Q37549946 P1476 Q37549946-140B65B7-A5ED-43FA-87BE-1E126DB37E98 @default.
• Q37549946 P2093 Q37549946-02540A86-7FAC-4A3C-95CD-F1F0F026DDAA @default.
• Q37549946 P2093 Q37549946-72C55987-4B46-42C8-8A6B-CEA15E0EA9FC @default.
• Q37549946 P2860 Q37549946-017ABF57-4A8F-48D6-ABC3-6528DEE5FFCA @default.
• Q37549946 P2860 Q37549946-0C5C1B6C-6B44-4FF9-B644-6ACD8EDF980A @default.
• Q37549946 P2860 Q37549946-0DE02D19-7A5C-47FE-B0B6-DA164CCADD59 @default.
• Q37549946 P2860 Q37549946-1030F1F0-2B65-4731-B9B9-13C89F487817 @default.
• Q37549946 P2860 Q37549946-1574F443-6C38-419A-A84F-C9D8926E1060 @default.
• Q37549946 P2860 Q37549946-164FECA8-DE9A-48B4-B1F0-259C186C738F @default.
• Q37549946 P2860 Q37549946-195679BD-14E8-44F0-B7A9-61183E306E95 @default.
• Q37549946 P2860 Q37549946-20305D71-B18D-420B-A49C-98DA43BBBFC4 @default.
• Q37549946 P2860 Q37549946-2280A4E8-1B23-4757-A2E5-42BF3CC261DF @default.
• Q37549946 P2860 Q37549946-2FBD5AC1-27EC-4028-8ECD-E01E72C07099 @default.
• Q37549946 P2860 Q37549946-41D62589-4193-439D-9A30-97AF7C59C7C7 @default.
• Q37549946 P2860 Q37549946-4F138F5A-51FC-4139-B097-05F45BE4BD63 @default.
• Q37549946 P2860 Q37549946-55633DC1-2E13-4692-9EB2-EE199B9C9418 @default.
• Q37549946 P2860 Q37549946-5EF77852-D457-415C-A9AB-DAB549326491 @default.
• Q37549946 P2860 Q37549946-6610B736-969E-4BC0-B811-E669FD76B8FC @default.
• Q37549946 P2860 Q37549946-73515AA9-5064-4E16-BD53-6ECC5CB272B7 @default.
• Q37549946 P2860 Q37549946-74F32E0E-0BB7-456D-A6C4-D6B07D678514 @default.
• Q37549946 P2860 Q37549946-76CAB39E-393A-4859-9B0C-3C71EB21C810 @default.
• Q37549946 P2860 Q37549946-78289E7A-DEB6-40D0-BB45-FBFBC2797E0C @default.
• Q37549946 P2860 Q37549946-7F82F265-B621-4BD2-8CD1-BFFDC9C46F48 @default.
• Q37549946 P2860 Q37549946-945A2FA4-71D7-44AC-95E3-FC502DE1333D @default.
• Q37549946 P2860 Q37549946-97465F22-F896-4DD0-A9B2-24B185BF866C @default.
• Q37549946 P2860 Q37549946-A9CD0D60-F481-4A2E-A850-2D847DFE7524 @default.
• Q37549946 P2860 Q37549946-B786309D-E780-4193-87D8-26F1DCB82EEA @default.
• Q37549946 P2860 Q37549946-C6D25E5D-EC4D-4F5C-83F5-ED1F4A101286 @default.
• Q37549946 P2860 Q37549946-C6E5FC1B-9D69-4DEE-8FFA-0AE7CBF975E0 @default.
• Q37549946 P2860 Q37549946-C99D35A1-4DCD-41C2-8AFF-1967805D7EA3 @default.
• Q37549946 P2860 Q37549946-DD395B3A-82B9-4E35-8259-D29DA582FDE6 @default.
• Q37549946 P2860 Q37549946-E44BEFA9-53A7-42D4-BA35-7D94BBEE9AAA @default.
• Q37549946 P2860 Q37549946-EAC57C12-9AF3-414A-B4F9-1072F347B960 @default.
• Q37549946 P2860 Q37549946-EB2E43F2-B7B6-4382-B0D6-7AC0C2ECB4DD @default.
• Q37549946 P2860 Q37549946-EC8185E8-6C27-4138-A169-6C326ACB0AF6 @default.
• Q37549946 P2860 Q37549946-EE08D687-BB0C-4DCB-919E-F7DB3ED82C9E @default.
• Q37549946 P2860 Q37549946-EF9BA745-83B5-428C-9CF2-9025C752D421 @default.
• Q37549946 P2860 Q37549946-F6CDCB7F-6912-4398-A813-D932D21335DA @default.
• Q37549946 P2888 Q37549946-7F71F593-9744-4954-AEF7-94DF329F2038 @default.
• Q37549946 P304 Q37549946-51CCB4DA-F5A8-42CA-A4AA-C6C431E9F8A2 @default.
• Q37549946 P31 Q37549946-6507F629-D2AA-44F5-BF5B-04FDEC31CADE @default.
• Q37549946 P31 Q37549946-6ce9ebe7-e077-437a-a964-29a9ab44fe5d @default.
• Q37549946 P356 Q37549946-EEAECF5D-6335-4831-B9E8-937DEA74FF9A @default.
• Q37549946 P433 Q37549946-BBF038D7-7683-4599-91F7-755CC8108E79 @default.
• Q37549946 P478 Q37549946-CA2F0BC6-E94E-4F20-92AB-4BB81C4018C6 @default.
• Q37549946 P577 Q37549946-779497CD-DAEE-4FFE-A812-AF18ADB261FD @default.
• Q37549946 P5875 Q37549946-D60738AB-6AF5-4BB6-AC85-6488E6CF2F38 @default.
• Q37549946 P698 Q37549946-DB141679-BC69-4BC5-8F83-D7E198D24281 @default.
• Q37549946 P921 Q37549946-FA10A9B7-52B3-4A9A-97FD-A1A033FF5012 @default.
• Q37549946 P356 PCAN.2009.25 @default.
• Q37549946 P698 19597531 @default.
• Q37549946 P1433 Q2108326 @default.
• Q37549946 P1476 "Measuring therapeutic efficacy in the changing paradigm of castrate-resistant prostate cancer" @default.
• Q37549946 P2093 "J A Schalken" @default.
• Q37549946 P2093 "P F Mulders" @default.
• Q37549946 P2860 Q24654019 @default.
• Q37549946 P2860 Q27824849 @default.
• Q37549946 P2860 Q29616218 @default.
• Q37549946 P2860 Q30080026 @default.
• Q37549946 P2860 Q33566395 @default.
• Q37549946 P2860 Q33638830 @default.
• Q37549946 P2860 Q33767866 @default.
• Q37549946 P2860 Q34604646 @default.
• Q37549946 P2860 Q34898980 @default.
• Q37549946 P2860 Q35751894 @default.
• Q37549946 P2860 Q35888368 @default.
• Q37549946 P2860 Q36589866 @default.
• Q37549946 P2860 Q36910156 @default.
• Q37549946 P2860 Q37255452 @default.
• Q37549946 P2860 Q37372813 @default.
• Q37549946 P2860 Q38786003 @default.
• Q37549946 P2860 Q39434957 @default.
• Q37549946 P2860 Q40333321 @default.

• next